Another drug used in breast cancer treatment is ICI 182,780 (ICI), a selective estrogen receptor down-regulator (SERD), a pure anti-estrogen, which can down-regulate the ER expression levels and promote its proteasomal degradation [11]. This evidence concerns the gene ESR1 and breast cancer.